RT Journal Article
SR Electronic
T1 Using proper mean generation intervals in modelling of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.25.21254307
DO 10.1101/2021.03.25.21254307
A1 Xiujuan Tang
A1 Salihu S. Musa
A1 Shi Zhao
A1 Daihai He
YR 2021
UL http://medrxiv.org/content/early/2021/04/15/2021.03.25.21254307.abstract
AB In susceptible-exposed-infectious-recovered (SEIR) epidemic models, with the exponentially distributed duration of exposed/infectious statuses, the mean generation interval (GI, time lag between infections of a primary case and its secondary case) equals the mean latent period (LP) plus the mean infectious period (IP). It was widely reported that the GI for COVID-19 is as short as 5 days. However, many works in top journals used longer LP or IP with the sum (i.e., GI), e.g., > 7 days. This discrepancy will lead to overestimated basic reproductive number, and exaggerated expectation of infectious attack rate and control efficacy, since all these quantities are functions of basic reproductive number. We argue that it is important to use suitable epidemiological parameter values.Competing Interest StatementDH was supported by an Alibaba (China) Co. Ltd Collaborative Research Project. Other authors declared no conflict of interests.Funding StatementDH was supported by an Alibaba (China) Co. Ltd Collaborative Research grant (ZG9Z). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are publicly available.